| 1 | Identification and characterization of the thalamic ventral posterior complex by 11.7T ex vivo diffusion tensor imaging | 1.6 | 4 | Citations (PDF) |
| 2 | Multidimensional MRI reveals cortical astrogliosis linked to dementia in Alzheimer’s disease | 2.0 | 8 | Citations (PDF) |
| 3 | The autophagy adaptor TRIAD3A promotes tau fibrillation by nested phase separation | 12.8 | 26 | Citations (PDF) |
| 4 | Mass Spectrometry–Based Proteomics Analysis of Human Substantia Nigra From Parkinson's Disease Patients Identifies Multiple Pathways Potentially Involved in the Disease | 3.5 | 58 | Citations (PDF) |
| 5 | Hippocampal synaptic alterations associated with tau pathology in primary age-related tauopathy | 1.5 | 11 | Citations (PDF) |
| 6 | Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer’s Disease Continuum | 1.7 | 23 | Citations (PDF) |
| 7 | Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer’s disease neuropathologic changes and cognitive decline | 5.8 | 47 | Citations (PDF) |
| 8 | Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer’s Disease | 3.4 | 51 | Citations (PDF) |
| 9 | Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson’s disease | 8.2 | 33 | Citations (PDF) |
| 10 | Activated endothelial cells induce a distinct type of astrocytic reactivity | 3.1 | 45 | Citations (PDF) |
| 11 | STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy | 5.3 | 220 | Citations (PDF) |
| 12 | Quantitative proteomic analysis of the frontal cortex in Alzheimer’s disease | 2.7 | 62 | Citations (PDF) |
| 13 | Persistently Elevated mTOR Complex 1-S6 Kinase 1 Disrupts DARPP-32–Dependent D1 Dopamine Receptor Signaling and Behaviors | 4.2 | 14 | Citations (PDF) |
| 14 | Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease | 1.9 | 25 | Citations (PDF) |
| 15 | Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy | 1.5 | 72 | Citations (PDF) |
| 16 | GDE2-RECK controls ADAM10 α-secretase–mediated cleavage of amyloid precursor protein | 8.7 | 38 | Citations (PDF) |
| 17 | NMDA Receptor Antagonism for Neuroprotection in a Canine Model of Hypothermic Circulatory Arrest | 1.0 | 5 | Citations (PDF) |
| 18 | Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease | 3.4 | 180 | Citations (PDF) |
| 19 | Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study | 4.2 | 94 | Citations (PDF) |
| 20 | Abnormal brain cholesterol homeostasis in Alzheimer’s disease—a targeted metabolomic and transcriptomic study | 5.4 | 142 | Citations (PDF) |
| 21 | TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson’s diseaseNeuron, 2021, 109, 3758-3774.e11 | 8.6 | 54 | Citations (PDF) |
| 22 | Genome-wide association study and functional validation implicates JADE1 in tauopathy | 5.8 | 34 | Citations (PDF) |
| 23 | A brain proteomic signature of incipient Alzheimer’s disease in youngAPOEε4 carriers identifies novel drug targets | 8.2 | 53 | Citations (PDF) |
| 24 | Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementiaBrain, 2020, 143, 234-248 | 6.0 | 236 | Citations (PDF) |
| 25 | Influence of species and processing parameters on recovery and content of brain tissue‐derived extracellular vesicles | 11.1 | 120 | Citations (PDF) |
| 26 | A consensus proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation | 0.9 | 0 | Citations (PDF) |
| 27 | Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain | 11.4 | 158 | Citations (PDF) |
| 28 | Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls | 1.1 | 33 | Citations (PDF) |
| 29 | Diffeomorphic Registration With Intensity Transformation and Missing Data: Application to 3D Digital Pathology of Alzheimer's Disease | 2.0 | 42 | Citations (PDF) |
| 30 | Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study | 4.2 | 135 | Citations (PDF) |
| 31 | Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation | 22.8 | 989 | Citations (PDF) |
| 32 | Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington’s disease | 2.1 | 18 | Citations (PDF) |
| 33 | Mapping tracts in the human subthalamic area by 11.7T ex vivo diffusion tensor imaging | 1.6 | 26 | Citations (PDF) |
| 34 | α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment | 9.7 | 62 | Citations (PDF) |
| 35 | C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy | 5.8 | 57 | Citations (PDF) |
| 36 | Neurotransmitter Imbalance in the Brain and Alzheimer’s Disease Pathology | 1.7 | 82 | Citations (PDF) |
| 37 | Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer’s disease | 4.4 | 55 | Citations (PDF) |
| 38 | Heritability and genetic variance of dementia with Lewy bodies | 3.6 | 40 | Citations (PDF) |
| 39 | Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing | 14.1 | 3,000 | Citations (PDF) |
| 40 | The “Race” Toward Diversity, Inclusion, and Equity in Pathology: The Johns Hopkins Experience | 1.2 | 24 | Citations (PDF) |
| 41 | Genetic analysis of neurodegenerative diseases in a pathology cohort | 2.4 | 47 | Citations (PDF) |
| 42 | Neuropathologic, genetic, and longitudinal cognitive profiles in primary age‐related tauopathy (PART) and Alzheimer's disease | 0.9 | 119 | Citations (PDF) |
| 43 | PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R) | 5.3 | 198 | Citations (PDF) |
| 44 | A comprehensive screening of copy number variability in dementia with Lewy bodies | 2.4 | 17 | Citations (PDF) |
| 45 | Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis | 2.8 | 17 | Citations (PDF) |
| 46 | Genome-wide Analyses Identify KIF5A as a Novel ALS Gene | 8.6 | 690 | Citations (PDF) |
| 47 | Domain‐specific cognitive impairment in non‐demented Parkinson's disease psychosis | 1.5 | 11 | Citations (PDF) |
| 48 | Evidence for brain glucose dysregulation in Alzheimer's disease | 0.9 | 492 | Citations (PDF) |
| 49 | Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study | 12.1 | 279 | Citations (PDF) |
| 50 | Discovery of noncanonical translation initiation sites through mass spectrometric analysis of protein N termini | 3.2 | 91 | Citations (PDF) |
| 51 | Onset and Remission of Psychosis in Parkinson's Disease: Pharmacologic and Motoric Markers | 1.3 | 10 | Citations (PDF) |
| 52 | Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques | 2.7 | 17 | Citations (PDF) |
| 53 | Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease | 9.7 | 246 | Citations (PDF) |
| 54 | Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia | 1.5 | 27 | Citations (PDF) |
| 55 | Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease | 26.5 | 476 | Citations (PDF) |
| 56 | Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer’s Disease | 8.6 | 443 | Citations (PDF) |
| 57 | SCA
8
RAN
polySer protein preferentially accumulates in white matter regions and is regulated by
eIF
3F | 5.2 | 80 | Citations (PDF) |
| 58 | Ventricular and Periventricular Anomalies in the Aging and Cognitively Impaired Brain | 2.7 | 52 | Citations (PDF) |
| 59 | The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype | 2.4 | 61 | Citations (PDF) |
| 60 | Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study | 4.2 | 474 | Citations (PDF) |
| 61 | Novel genetic loci associated with hippocampal volume | 11.0 | 299 | Citations (PDF) |
| 62 | Expression of mutant DISC1 in Purkinje cells increases their spontaneous activity and impairs cognitive and social behaviors in mice | 3.6 | 22 | Citations (PDF) |
| 63 | Mutant Huntingtin Disrupts the Nuclear Pore Complex | 8.6 | 374 | Citations (PDF) |
| 64 | Cryptic exon incorporation occurs in Alzheimer’s brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43 | 5.8 | 102 | Citations (PDF) |
| 65 | ADORA1 mutations are not a common cause of Parkinson's disease and dementia with Lewy bodies | 3.2 | 13 | Citations (PDF) |
| 66 | A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease | 3.7 | 522 | Citations (PDF) |
| 67 | Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease | 14.1 | 1,017 | Citations (PDF) |
| 68 | Elucidation of White Matter Tracts of the Human Amygdala by Detailed Comparison between High-Resolution Postmortem Magnetic Resonance Imaging and Histology | 1.3 | 44 | Citations (PDF) |
| 69 | MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy | 2.4 | 55 | Citations (PDF) |
| 70 | Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies 2017, 8, 257 | | 116 | Citations (PDF) |
| 71 | Rho‐associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid‐β levels in brain | 2.7 | 126 | Citations (PDF) |
| 72 | Clinicopathological correlates of depression in early Alzheimer's disease in the NACC | 1.5 | 30 | Citations (PDF) |
| 73 | Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease | 2.1 | 136 | Citations (PDF) |
| 74 | Novel genetic loci underlying human intracranial volume identified through genome-wide association | 11.4 | 241 | Citations (PDF) |
| 75 | Gait function and locus coeruleus Lewy body pathology in 51 Parkinson's disease patients | 2.0 | 8 | Citations (PDF) |
| 76 | Changes in the detergent‐insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression | 2.5 | 100 | Citations (PDF) |
| 77 | Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model | 8.6 | 162 | Citations (PDF) |
| 78 | Quantitative Proteomic Analysis Reveals Similarities between Huntington’s Disease (HD) and Huntington’s Disease-Like 2 (HDL2) Human Brains | 2.3 | 36 | Citations (PDF) |
| 79 | A culture–brain link: Negative age stereotypes predict Alzheimer’s disease biomarkers. | 1.6 | 177 | Citations (PDF) |
| 80 | Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1 | 11.0 | 76 | Citations (PDF) |
| 81 | A rapidly progressive dementia case with pathological diagnosis of FTLD-UPS | 5.8 | 0 | Citations (PDF) |
| 82 | Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies | 3.6 | 62 | Citations (PDF) |
| 83 | Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine NeuronsENeuro, 2016, 3, ENEURO.0183-16.2016 | 1.2 | 98 | Citations (PDF) |
| 84 | P4‐187: Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology, and presymptomatic cerebral amyloid accumulation | 0.9 | 1 | Citations (PDF) |
| 85 | Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12 | 3.2 | 42 | Citations (PDF) |
| 86 | Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models | 1.5 | 7 | Citations (PDF) |
| 87 | Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation | 1.5 | 93 | Citations (PDF) |
| 88 | Lysosomal Enzyme Glucocerebrosidase Protects against Aβ1-42 Oligomer-Induced Neurotoxicity | 1.5 | 19 | Citations (PDF) |
| 89 | Mouse Model for Protein Tyrosine Phosphatase D (PTPRD) Associations with Restless Leg Syndrome or Willis-Ekbom Disease and Addiction: Reduced Expression Alters Locomotion, Sleep Behaviors and Cocaine-Conditioned Place Preference | 4.4 | 57 | Citations (PDF) |
| 90 | O4‐12‐02: Protein co‐expression network analysis in Alzheimer's disease | 0.9 | 0 | Citations (PDF) |
| 91 | Common genetic variants influence human subcortical brain structures | 31.3 | 904 | Citations (PDF) |
| 92 | Probing region-specific microstructure of human cortical areas using high angular and spatial resolution diffusion MRI | 3.0 | 93 | Citations (PDF) |
| 93 | Aggregation Properties of the Small Nuclear Ribonucleoprotein U1-70K in Alzheimer Disease | 1.3 | 63 | Citations (PDF) |
| 94 | Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration | 2.1 | 146 | Citations (PDF) |
| 95 | The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes | 3.4 | 72 | Citations (PDF) |
| 96 | Characterization of tau oligomeric seeds in progressive supranuclear palsy | 3.4 | 90 | Citations (PDF) |
| 97 | The problem of axonal injury in the brains of veterans with histories of blast exposure | 3.4 | 88 | Citations (PDF) |
| 98 | Mild Cognitive Impairment and Asymptomatic Alzheimer Disease Subjects | 1.5 | 71 | Citations (PDF) |
| 99 | Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease | 12.2 | 191 | Citations (PDF) |
| 100 | C9orf72 nucleotide repeat structures initiate molecular cascades of disease | 31.3 | 912 | Citations (PDF) |
| 101 | Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases | 3.4 | 50 | Citations (PDF) |
| 102 | Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion | 2.4 | 23 | Citations (PDF) |
| 103 | Beta‐Amyloid, Phospho‐Tau and Alpha‐Synuclein Deposits Similar to Those in the Brain Are Not Identified in the Eyes of Alzheimer's and Parkinson's Disease Patients | 3.0 | 164 | Citations (PDF) |
| 104 | Neuroprotective effects of PPAR‐γ agonist rosiglitazone in N171‐82Q mouse model of Huntington's disease | 2.7 | 117 | Citations (PDF) |
| 105 | Personality and resilience to Alzheimer’s disease neuropathology: a prospective autopsy study | 2.4 | 105 | Citations (PDF) |
| 106 | Feasibility of creating a high-resolution 3D diffusion tensor imaging based atlas of the human brainstem: A case study at 11.7T | 3.0 | 72 | Citations (PDF) |
| 107 | Familial Dementia With Frontotemporal Features Associated With M146V Presenilin‐1 Mutation | 3.0 | 31 | Citations (PDF) |
| 108 | Hippocampal sclerosis dementia: An amnesic variant of frontotemporal degeneration | 0.8 | 15 | Citations (PDF) |
| 109 | PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity | 2.1 | 161 | Citations (PDF) |
| 110 | Repeat Expansion inC9ORF72in Alzheimer's Disease | 19.4 | 160 | Citations (PDF) |
| 111 | Meritorious Contributions to Neuropathology: | 1.5 | 0 | Citations (PDF) |
| 112 | Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques | 5.8 | 99 | Citations (PDF) |
| 113 | Endoplasmic Reticulum Stress Is Important for the Manifestations of α-SynucleinopathyIn Vivo | 2.3 | 374 | Citations (PDF) |
| 114 | Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain | 3.6 | 135 | Citations (PDF) |
| 115 | Passive (Amyloid-β) Immunotherapy Attenuates Monoaminergic Axonal Degeneration in the AβPPswe/PS1dE9 Mice | 1.7 | 20 | Citations (PDF) |
| 116 | Identification of Novel GDNF Isoforms and cis-Antisense GDNFOS Gene and Their Regulation in Human Middle Temporal Gyrus of Alzheimer Disease | 1.3 | 99 | Citations (PDF) |
| 117 | Alzheimer's Therapeutics: Translation of Preclinical Science to Clinical Drug Development | 3.8 | 45 | Citations (PDF) |
| 118 | Fine Mapping of Calcineurin (PPP3CA) Gene Reveals Novel Alternative Splicing Patterns, Association of 5′UTR Trinucleotide Repeat With Addiction Vulnerability, and Differential Isoform Expression in Alzheimer's Disease | 0.9 | 28 | Citations (PDF) |
| 119 | Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function | 5.3 | 276 | Citations (PDF) |
| 120 | Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain | 2.2 | 760 | Citations (PDF) |
| 121 | Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of AgeingBrain, 2010, 133, 2225-2231 | 6.0 | 66 | Citations (PDF) |
| 122 | Neuropathologic Studies of the Baltimore Longitudinal Study of Aging (BLSA) | 1.7 | 135 | Citations (PDF) |
| 123 | S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease | 5.3 | 152 | Citations (PDF) |
| 124 | ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain | 2.4 | 161 | Citations (PDF) |
| 125 | Amyloid precursor protein increases cortical neuron size in transgenic mice | 2.4 | 56 | Citations (PDF) |
| 126 | The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal | 0.9 | 81 | Citations (PDF) |
| 127 | Morphometry of the human substantia nigra in ageing and Parkinson’s disease | 5.8 | 178 | Citations (PDF) |
| 128 | Effect of infarcts on dementia in the Baltimore longitudinal study of aging | 4.7 | 217 | Citations (PDF) |
| 129 | Neuronal hypertrophy in asymptomatic Alzheimer's Disease in the BLSA | 2.3 | 0 | Citations (PDF) |
| 130 | Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms | 2.1 | 117 | Citations (PDF) |
| 131 | Biotinylated anti-Aβ antibody as a tool to diagnose pre-clinical stages of Alzheimer disease (AD) | 1.5 | 0 | Citations (PDF) |
| 132 | Differential nuclear and nucleolar hypertrophy of anterior and posterior cingulate neurons in asymptomatic subjects with AD pathology | 1.5 | 0 | Citations (PDF) |
| 133 | Rates of Depression in Individuals With Pathologic But Not Clinical Alzheimer Disease are Lower Than Those in Individuals Without the Disease: Findings From the Baltimore Longitudinal Study on Aging (BLSA) | 0.9 | 11 | Citations (PDF) |
| 134 | Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons | 2.4 | 102 | Citations (PDF) |
| 135 | Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: A real-time PCR study | 2.0 | 150 | Citations (PDF) |
| 136 | The Prevalence of Alzheimer Neuropathologic Lesions Is Similar in Blacks and Whites | 1.5 | 31 | Citations (PDF) |
| 137 | Early involvement of small inhibitory cortical interneurons in Alzheimer’s disease | 5.8 | 42 | Citations (PDF) |
| 138 | Papillomavirus-Like Particles Are an Effective Platform for Amyloid-β Immunization in Rabbits and Transgenic Mice | 0.8 | 55 | Citations (PDF) |
| 139 | Causes of Unexpected Death in Patients With Multiple Sclerosis | 0.4 | 22 | Citations (PDF) |
| 140 | -Synuclein Phosphorylation Enhances Eosinophilic Cytoplasmic Inclusion Formation in SH-SY5Y Cells | 2.3 | 263 | Citations (PDF) |
| 141 | Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases | 2.4 | 210 | Citations (PDF) |
| 142 | Role of Alzheimer's disease models in designing and testing experimental therapeutics | 1.7 | 1 | Citations (PDF) |
| 143 | Stabilization of -Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation | 2.3 | 178 | Citations (PDF) |
| 144 | In vitro assembly properties of mutant and chimeric intermediate filament proteins: insight into the function of sequences in the rod and end domains of IF | 2.1 | 10 | Citations (PDF) |
| 145 | Hippocampal neurons in pre-clinical Alzheimer’s disease | 2.4 | 299 | Citations (PDF) |
| 146 | Neuronal localization of C1q in preclinical Alzheimer's disease | 3.6 | 75 | Citations (PDF) |
| 147 | NDRG2: a novel Alzheimer's disease associated protein | 3.6 | 127 | Citations (PDF) |
| 148 | Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease | 5.3 | 1,099 | Citations (PDF) |
| 149 | Immune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease | 2.4 | 225 | Citations (PDF) |
| 150 | Apolipoprotein E ε4 and short-term recovery from predominantly mild brain injury | 0.7 | 134 | Citations (PDF) |
| 151 | The prevalence of the neuropathological lesions of Alzheimer’s disease is independent of race and gender | 2.4 | 67 | Citations (PDF) |
| 152 | A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion | 4.7 | 115 | Citations (PDF) |
| 153 | A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion | 4.7 | 165 | Citations (PDF) |
| 154 | β-Amyloid Peptide Vaccination Results in Marked Changes in Serum and Brain A β Levels in APPswe/PS1ΔE9 Mice, as Detected by SELDI-TOF-Based ProteinChip ® Technology | 1.7 | 49 | Citations (PDF) |
| 155 | Intraneuronal Aβ-Amyloid Precedes Development of Amyloid Plaques in Down Syndrome | 1.7 | 255 | Citations (PDF) |
| 156 | Decreasing Incidence of Sudden Death Due to Undiagnosed Primary Central Nervous System Tumors | 1.7 | 33 | Citations (PDF) |
| 157 | Transglutaminase-Induced Cross-Linking of Tau Proteins in Progressive Supranuclear Palsy | 1.5 | 63 | Citations (PDF) |
| 158 | Endocytic Pathway Abnormalities Precede Amyloid β Deposition in Sporadic Alzheimer’s Disease and Down Syndrome | 2.8 | 856 | Citations (PDF) |
| 159 | Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease | 4.7 | 146 | Citations (PDF) |
| 160 | Neuropathology of preclinical and clinical lateonset Alzheimer's disease | 4.7 | 92 | Citations (PDF) |
| 161 | Loss of the Presynaptic Vesicle Protein Synaptophysin in Hippocampus Correlates with Cognitive Decline in Alzheimer Disease | 1.5 | 534 | Citations (PDF) |
| 162 | Increased Susceptibility of Alzheimer's Disease Temporal Cortex to Oxygen Free Radical-Mediated Processes | 2.6 | 84 | Citations (PDF) |
| 163 | Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. | 6.8 | 158 | Citations (PDF) |
| 164 | Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging | 2.4 | 144 | Citations (PDF) |
| 165 | Lack of association of the apoE4 allele with hippocampal sclerosis dementia | 1.3 | 26 | Citations (PDF) |
| 166 | Differential Binding of Apolipoprotein E Isoforms to Tau and Other Cytoskeletal Proteins | 3.0 | 85 | Citations (PDF) |
| 167 | In Situ Labeling of Dying Cortical Neurons in Normal Aging and in Alzheimer's Disease: Correlations with Senile Plaques and Disease Progression | 1.5 | 90 | Citations (PDF) |
| 168 | α-Calcium-Calmodulin-Dependent Kinase II is Associated with Paired Helical Filaments of Alzheimerʼs Disease | 1.5 | 46 | Citations (PDF) |
| 169 | Apolipoprotein E Genotype and the Rate of Decline in Probable Alzheimer Disease-Reply | 6.9 | 0 | Citations (PDF) |
| 170 | Apolipoprotein E Genotype and Rate of Decline in Probable Alzheimer's Disease | 6.9 | 109 | Citations (PDF) |
| 171 | Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease | 31.3 | 237 | Citations (PDF) |
| 172 | Metal-catalyzed oxidation of bovine neurofilaments in vitro | 2.6 | 35 | Citations (PDF) |
| 173 | Comparison of New and Traditional Methods for Detection of Senile Plaques in Alzheimer's Disease | 1.7 | 4 | Citations (PDF) |
| 174 | Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease | 45.2 | 1,223 | Citations (PDF) |
| 175 | Phosphorylation Modulates Calpain-Mediated Proteolysis and Calmodulin Binding of the 200-kDa and 160-kDa Neurofilament Proteins | 2.7 | 86 | Citations (PDF) |
| 176 | In vitro polymerization of oxidized tau into filaments | 1.9 | 89 | Citations (PDF) |
| 177 | EEG and prognosis of neurologic recovery of dogs under profound hypothermic circulatory arrest | 2.5 | 7 | Citations (PDF) |
| 178 | A new series of trpE vectors that enable high expression of nonfusion proteins in bacteria | 1.1 | 6 | Citations (PDF) |
| 179 | Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy | 4.7 | 220 | Citations (PDF) |
| 180 | The regulatory role of calmodulin in the proteolysis of individual neurofilament proteins by calpain | 2.7 | 56 | Citations (PDF) |
| 181 | A QUICK SILVER METHOD FOR SENILE PLAQUES AND A COMPARISON OF EIGHT METHODS FOR THE DEMONSTRATION OF SENILE PLAQUES | 1.5 | 4 | Citations (PDF) |
| 182 | THE PINEAL GLAND IN AGING AND ALZHEIMERʼS DISEASE | 1.5 | 0 | Citations (PDF) |
| 183 | Neuronal Disorders: Studies of Animal Models and Human Diseases | 1.0 | 4 | Citations (PDF) |
| 184 | Effect of aluminum and other multivalent cations on neurofilaments in vitro: An electron microscopic study | 1.5 | 65 | Citations (PDF) |
| 185 | The effect of aluminum on markers for synaptic neurotransmission, cyclic AMP, and neurofilaments in a neuroblastoma × glioma hybridoma (NG108-15) | 1.9 | 17 | Citations (PDF) |
| 186 | INTRAVASCULAR MALIGNANT LYMPHOMATOSIS | 1.5 | 1 | Citations (PDF) |
| 187 | Bilateral opercular polymicrogyria | 4.7 | 85 | Citations (PDF) |
| 188 | ALUMINUM-INDUCED NEUROFILAMENTOUS CHANGES IN CULTURED RAT DORSAL ROOT GANGLIA EXPLANTS | 1.5 | 4 | Citations (PDF) |
| 189 | Dural scrofula | 0.7 | 5 | Citations (PDF) |
| 190 | Aluminum neurotoxicity: altered expression of cytoskeletal genes | 2.5 | 82 | Citations (PDF) |
| 191 | Research on Rett Syndrome: Strategy and Preliminar Results | 1.0 | 14 | Citations (PDF) |
| 192 | Neurofilamentous Abnormalities in Motor Neurons in Spontaneously Occurring Animal Disorders | 1.5 | 55 | Citations (PDF) |
| 193 | NORMAL AND ABNORMAL ASSEMBLY OF NEUROFILAMENTS IN VITRO | 1.5 | 0 | Citations (PDF) |
| 194 | Immunocytochemical studies of neurofilament antigens in the neurofibrillary pathology induced by aluminum | 1.9 | 133 | Citations (PDF) |
| 195 | Hematogenous origin of brain macrophages | 0.7 | 8 | Citations (PDF) |
| 196 | IMMUNOCYTOCHEMICAL STUDIES OF NEUROFILAMENT ANTIGENS IN THE NEUROFIBRILLARY PATHOLOGY INDUCED BY ALUMINUM | 1.5 | 8 | Citations (PDF) |
| 197 | Canine Inherited Ataxia | 1.5 | 11 | Citations (PDF) |
| 198 | Aluminum intoxication: a disorder of neurofilament transport in motor neurons | 1.9 | 109 | Citations (PDF) |
| 199 | Synaptic Neurochemical Alterations Associated with Neuronal Degeneration in an Inherited Cerebellar Ataxia of Gordon Setters | 1.5 | 12 | Citations (PDF) |
| 200 | Canine Neuroaxonal Dystrophy | 1.5 | 72 | Citations (PDF) |
| 201 | 24 CHANGES OF MOTOR NEURON CHOLINERGIC RECEPTORS AFTER AXOTOMY | 1.5 | 0 | Citations (PDF) |
| 202 | Neurofibrillary axonal pathology in aluminum intoxication | 4.7 | 106 | Citations (PDF) |
| 203 | Canine inherited ataxia | 4.7 | 25 | Citations (PDF) |
| 204 | Model of Wernicke's Encephalopathy | 6.9 | 151 | Citations (PDF) |
| 205 | Clinical Features of Inherited Cerebellar Degeneration in Gordon Setters | 0.0 | 18 | Citations (PDF) |
| 206 | Visual Evoked Responses in Pernicious Anemia | 6.9 | 60 | Citations (PDF) |
| 207 | TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau | 1.0 | 140 | Citations (PDF) |
| 208 | NPTX2 and cognitive dysfunction in Alzheimer’s Disease | 1.0 | 234 | Citations (PDF) |
| 209 | Discovery of several thousand highly diverse circular DNA viruses | 1.0 | 178 | Citations (PDF) |
| 210 | Title is missing! 0 | | 2 | Citations (PDF) |
| 211 | Neuropathologic findings in a community-based autopsy cohort of older, virally suppressed, people with HIV | 1.5 | 4 | Citations (PDF) |
| 212 | Spatially resolved transcriptomic profiling identifies distinct signatures in parenchymal and vascular microenvironments in Alzheimer's Disease with Cerebral Amyloid Angiopathy | 0.9 | 0 | Citations (PDF) |
| 213 | Neuropathologic Characterisation of Mitochondrial Membrane Protein–Associated Neurodegeneration (MPAN) With Coexisting α‐Synuclein and Tau Pathology in a Young Adult | 1.9 | 0 | Citations (PDF) |
| 214 | Amyloid plaques associated with shift in patterns of hippocampal tau pathology in middle age | 1.7 | 0 | Citations (PDF) |
